| Dokumentenart: | Artikel | ||||
|---|---|---|---|---|---|
| Titel eines Journals oder einer Zeitschrift: | Der Onkologe | ||||
| Verlag: | Springer | ||||
| Ort der Veröffentlichung: | NEW YORK | ||||
| Band: | 22 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 3 | ||||
| Seitenbereich: | S. 192-197 | ||||
| Datum: | 2016 | ||||
| Institutionen: | Medizin > Zentren des Universitätsklinikums Regensburg > Tumorzentrum e.V. | ||||
| Identifikationsnummer: |
| ||||
| Stichwörter / Keywords: | COLON-CANCER; IMPROVEMENT; Clinical cancer registries; Cancer; Colorectal cancer; Quality management; Health services research | ||||
| Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||
| Status: | Veröffentlicht | ||||
| Begutachtet: | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden: | Ja | ||||
| Dokumenten-ID: | 41861 |
Zusammenfassung
The routine care of cancer patients differs from the setting of randomized controlled clinical trials. In routine care patients of all age groups are treated and often suffer from multiple comorbidities, therefore results from clinical trials cannot always be directly applied to the routine care setting. The aim of this review is to collate the clinical cancer registry data regarding questions of ...
Zusammenfassung
The routine care of cancer patients differs from the setting of randomized controlled clinical trials. In routine care patients of all age groups are treated and often suffer from multiple comorbidities, therefore results from clinical trials cannot always be directly applied to the routine care setting. The aim of this review is to collate the clinical cancer registry data regarding questions of quality of care and health services research. By the implementation of the further development of the early detection of cancer and quality assurance through clinical cancer registries Act (KFRG A 65c Social Code V, SGB V) in 2013 the gap between the results from clinical trials and comprehensive routine care settings will be filled and the "last mile" (H. Pfaff) with the many facets of quality of process and results will be reflected by healthcare research. The instruments necessary to collate, combine and evaluate the quality of oncological treatment according to clearly defined questions, are systematic documentation and analysis of the routine care setting. This report gives an introduction to the methodology of cancer registries and shows which types of questions can be investigated with such register data based on two examples. Outcome data from nationwide clinical cancer registries were collected and are presented according to existing quality indicators from the guidelines on treatment quality. The distribution and survival benefit of stage II colon cancer patients were reviewed based on the quality indicators for the number of lymph nodes examined nationwide (12 or more lymph nodes should be removed and examined). Similarly, the outcome of adjuvant chemotherapy in patients with stage II colon cancer is presented using a population-based regional cancer registry. The nationwide analysis of the quality indicators showed a significantly better survival for patients when more than 12 lymph nodes were removed and examined than for patients when less than 12 lymph nodes were removed. In the regional analysis patients with stage II colon cancer and T4 tumors showed a significantly benefit from adjuvant chemotherapy. This report identifies ways in which register data for the measurement of the quality of treatment and for health services research can be utilized.
Metadaten zuletzt geändert: 17 Mrz 2020 11:01
Altmetric